Pulmonx Corporation (LUNG) Tops Q4 EPS by 12c

Pulmonx Corporation (NASDAQ: LUNG) reported Q4 EPS of ($0.33), $0.12 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $23.8 million versus the consensus estimate of $22.29 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Full Truck Alliance (YMM) Tops Q2 EPS by 10c; beats on guidance
• UBS Upgrades Kingspan Group PLC (KSP:ID) to Buy
• Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance